340B Update: HRSA Proposes Penalties for Drug Manufacturers that Overcharge Covered Entities
By EsqSocial Corporation 24/06/15
On June 16, 2015, the U.S. Department of Health and Human Services (“HHS”) and the Health Resources and Services Administration (“HRSA”) released proposed rules on civil monetary penalties and drug ceiling prices under the 340B Drug Pricing Program...
By: K&L Gates LLP